New Issue: JPMorgan prices $7.97 million 11.75% callable contingent interest notes on S&P 500, SPDR S&P Biotech

New York, Dec. 29 – JPMorgan Chase Financial Co. LLC priced $7.97 million of callable contingent interest notes due Dec. 24, 2026 linked to the S&P 500 index and SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 11.75%.

If the worst performing asset gains or ends above its 60% downside threshold the payout at maturity will be par plus the coupon. Investors will lose 1% for every 1% that the worst performing asset declines if it finishes below its downside threshold level.

The securities may be called starting June 26, 2024 at par and on any subsequent determination date.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the agent.

Issuer:	JPMorgan Chase Financial Co. LLC
Guarantor:	JPMorgan Chase & Co.
Issue:	Callable contingent interest notes
Underlying assets:	S&P 500 index and SPDR S&P Biotech ETF
Amount:	$7,974,000
Maturity:	Dec. 24, 2026
Coupon:	11.75%
Price:	Par
Payout at maturity:	If worst performing asset finishes at or above its downside threshold level, par; 1% loss for every 1% that worst performing asset declines if it finishes below its downside threshold level
Call:	Starting June 26, 2024 at par and on any subsequent determination date
Initial levels:	4,746.75 for S&P 500, $84.67 for SPDR S&P Biotech ETF
Downside thresholds:	2,848.05 for S&P 500, $50.802 for SPDR S&P Biotech ETF, 60% of initial level
Pricing date:	Dec. 21
Settlement date:	Dec. 27
Agent:	J.P. Morgan Securities LLC
Fees:	0%
Cusip:	48134RE61

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.